Advanced search
Publication Cover
Cancer Investigation Volume 31, 2013 - Issue 9
Submit an article Journal homepage
237
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Routine Histopathologic Characteristics Can Predict Oncotype DXTM Recurrence Score in Subsets of Breast Cancer Patients

Malcolm D. MattesRadiation Oncology Department, NY Methodist Hospital, Weill Medical College of Cornell University, Brooklyn, New York, USA,Correspondence[email protected]
,
Justin M. MannSUNY Upstate Medical University, School of Medicine, Syracuse, New York, USA
,
Hani AshamallaRadiation Oncology Department, NY Methodist Hospital, Weill Medical College of Cornell University, Brooklyn, New York, USA,
&
Ajay TejwaniRadiation Oncology Department, NY Methodist Hospital, Weill Medical College of Cornell University, Brooklyn, New York, USA,
Pages 604-606 | Received 16 Sep 2013, Accepted 18 Sep 2013, Published online: 28 Oct 2013

REFERENCES

  • Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817–2826.
  • Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24:3726–3734.
  • National Comprehensive Cancer Network® (NCCN). Practice Guidelines in Oncology: Breast Cancer, Version 3. Fort Washington, PA: National Comprehensive Cancer Network, Inc, 2012. www.nccn.org
  • College of American Pathologists. Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast. Version InvasiveBreast 3.1.0.0. Northfield, IL: College of American Pathologist. www.cap.org.
  • Auerbach J, Kim M, Fineberg S. Can features evaluated in the routine pathologic assessment of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX recurrence score? Arch Pathol Lab Med 2010;134:1697–1701.
  • Allison KH, Kandalaft PL, Sitlani CM, Dintzis SM, Gown AM. Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing? Breast Cancer Res Treat 2012;131:413–424.
  • Flanagan MB, Dabbs DJ, Brufsky AM, Beriwal S, Bhargava R. Histopathologic variables predict Oncotype DX recurrence score. Mod Pathol 2008;21:1255–1261.
  • Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, McMahon L, Yang Q, Shayne M, Huston A, Skinner KA, Griggs J, Lyman G. A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Cancer Invest 2010;28:978–982.
  • Cuzick J, Dowsett M, Wale C, Salter J, Quinn E, Zabaglo L, Howell A, Buzdar A, Forbes JF. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2011;29:4273–4278.
  • Clark BZ, Dabbs DJ, Cooper, KL, Bhargava R. Impact of Progesterone Receptor Semiquantitative Immunohistochemical Result on Oncotype DX Recurrence score: A Quality Assurance Study of 1074 Cases. Appl Immunohistochem Mol Morphol 2013;21:287–291.
  • Geradts J, Bean SM, Bentley RC, Barry WT. The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. Cancer Invest 2010;28:969–977.
  • Klein ME, Dabbs DJ, Shuai Y, Brufsky AM, Jankowitz R, Puhalla SL, Bhargava R. Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis. Mod Pathol 2013;26:658–664.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.